Lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro.

Two human pancreatic cell lines, MIA PaCa 2 and Capan 2, were treated by photodynamic therapy in vitro with Photophrin (0.01-25 micrograms/ml; 24 h) and then light (1-50 J/cm2; lambda = 630 nm). The following model was fit to 6 datasets with weighted nonlinear regression: [sequence: see text] The symbols are: E, cell growth; Econ, control growth in the absence of the combination; B, background signal; m, slope parameter; gamma, interaction parameter; D, concentration of Photofrin; L, light dose; F, fraction of Photofrin not photobleached by the light dose; k, k1, k2, bleaching parameters; A, distribution parameter for biexponential bleaching equation. Simple reciprocity of photosensitizer concentration and light dose was not found; compensation for photobleaching was critical. MIA PaCa2 required the monoexponential bleaching factor, whereas Capan 2 required the biexponential bleaching factor. The greater photosensitivity of MIA PaCa2 over Capan 2 can be best explained not by differences in the interaction parameter but rather by differences in the photobleaching pattern and rate. It may be possible to further enhance the selectivity of photodynamic therapy if differences in photobleaching between different cell types can be exploited by adequate dosimetry.

[1]  W D Holder,et al.  The nude mouse as a model for the study of human pancreatic cancer. , 1989, The Journal of surgical research.

[2]  K. Brackett,et al.  Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma , 1988, Journal of surgical oncology.

[3]  D. Dolphin,et al.  Preliminary studies on a more effective phototoxic agent than hematoporphyrin. , 1987, Journal of the National Cancer Institute.

[4]  A. Kyriazis,et al.  Morphological, biological, biochemical, and karyotypic characteristics of human pancreatic ductal adenocarcinoma Capan-2 in tissue culture and the nude mouse. , 1986, Cancer research.

[5]  L. Sheiner,et al.  Understanding the Dose-Effect Relationship , 1981, Clinical pharmacokinetics.

[6]  B. Henderson,et al.  DRUG and LIGHT DOSE DEPENDENCE OF PHOTODYNAMIC THERAPY: A STUDY OF TUMOR and NORMAL TISSUE RESPONSE , 1987, Photochemistry and photobiology.

[7]  T. Mang,et al.  PHOTODYNAMIC THERAPY IN THE TREATMENT OF PANCREATIC CARCINOMA: DIHEMATOPORPHYRIN ETHER UPTAKE and PHOTOBLEACHING KINETICS , 1987, Photochemistry and photobiology.

[8]  W. Potter,et al.  DRUG AND LIGHT DOSE DEPENDENCE OF PHOTODYNAMIC THERAPY: A STUDY OF TUMOR CELL CLONOGENICITY AND HISTOLOGIC CHANGES , 1987, Photochemistry and photobiology.

[9]  J. Moan,et al.  Porphyrin-sensitized photoinactivation of cells in vitro. , 1984, Progress in clinical and biological research.

[10]  R. Rees,et al.  THE PHOTOKILLING OF BLADDER CARCINOMA CELLS in vitro BY PHENOTHIAZINE DYES , 1990, Photochemistry and photobiology.

[11]  Peter M. Schlag,et al.  Individual in-vitro sensitivities of human pancreatic carcinoma cell lines to photodynamic therapy , 1992, Photonics West - Lasers and Applications in Science and Engineering.

[12]  S. Gibson,et al.  INTERDEPENDENCE OF FLUENCE, DRUG DOSE and OXYGEN ON HEMATOPORPHYRIN DERIVATIVE INDUCED PHOTOSENSITIZATION OF TUMOR MITOCHONDRIA , 1985, Photochemistry and photobiology.

[13]  W R Greco,et al.  Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. , 1990, Cancer research.

[14]  T. Dougherty,et al.  MEMBRANE LYSIS IN CHINESE HAMSTER OVARY CELLS TREATED WITH HEMATOPORPHYRIN DERIVATIVE PLUS LIGHT , 1982, Photochemistry and photobiology.

[15]  A. Hill,et al.  The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves , 1910 .

[16]  I. Forbes,et al.  Photocytotoxicity in vivo of haematoporphyrin derivative components. , 1985, Cancer letters.

[17]  T. Dougherty,et al.  Aspects of the cellular uptake and retention of hematoporphyrin derivative and their correlation with the biological response to PRT in vitro. , 1983, Advances in experimental medicine and biology.

[18]  C. Metzler,et al.  Estimation of pharmacokinetic parameters: statistical considerations. , 1981, Pharmacology and Therapeutics.

[19]  D. Dolphin,et al.  In vitro EVALUATION OF PHOTOTOXIC PROPERTIES OF FOUR STRUCTURALLY RELATED BENZOPORPHYRIN DERIVATIVES , 1990, Photochemistry and photobiology.

[20]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.